(Q35581140)

9 August 2017

1 reference

title

Emerging treatments for asthma (English)

1 reference

9 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1517/14728214.8.1.71

31 March 2024

author name string

Kate Blease

1

1 reference

9 August 2017

Alan Lewis

2

1 reference

9 August 2017

Heather K. Raymon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14610913

31 March 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

9 August 2017

http://www.tandfonline.com/doi/pdf/10.1517/14728214.8.1.71

1 reference

https://api.crossref.org/works/10.1517/14728214.8.1.71

Expert Opinion on Emerging Drugs

31 March 2024

published in

1 reference

9 August 2017

volume

8

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

71-81

1 reference

Asthma. From bronchoconstriction to airways inflammation and remodeling

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Inflammation, inflammatory mediators, and mediator antagonists in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Airway remodelling in the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Analysis of novel disease-related genes in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

IL-5-induced airway eosinophilia--the key to asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Th1/Th2 lymphocyte polarization in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Is Th1 the solution for Th2 in asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Interleukin-12: potential role in asthma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Omalizumab (Xolair) improves quality of life in adult patients with allergic asthma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Transcription factors and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

The JNK signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Protein tyrosine kinase structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

A novel transcription factor inhibitor, SP100030, inhibits cytokine gene expression, but not airway eosinophilia or hyperresponsiveness in sensitized and allergen-exposed rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

JAK-STAT signaling in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Cytokine traps: multi-component, high-affinity blockers of cytokine action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

DNA antisense therapy for asthma in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.1.71

Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge

21 January 2018

9

1 reference

https://api.crossref.org/works/10.1517/14728214.8.1.71

Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma

31 March 2024

11

1 reference

https://api.crossref.org/works/10.1517/14728214.8.1.71

Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma

31 March 2024

12

1 reference

https://api.crossref.org/works/10.1517/14728214.8.1.71

Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma

31 March 2024

13

1 reference

https://api.crossref.org/works/10.1517/14728214.8.1.71

Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia

31 March 2024

17

1 reference

https://api.crossref.org/works/10.1517/14728214.8.1.71

Adenosine in bronchoalveolar lavage fluid in asthma

31 March 2024

26

1 reference

https://api.crossref.org/works/10.1517/14728214.8.1.71

STAT6 deficiency in a mouse model of allergen-induced airways inflammation abolishes eosinophilia but induces infiltration of CD8+ T cells.

31 March 2024

39

1 reference

https://api.crossref.org/works/10.1517/14728214.8.1.71

Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium

31 March 2024

41

1 reference

https://api.crossref.org/works/10.1517/14728214.8.1.71

31 March 2024

Identifiers

1 reference

9 August 2017

1 reference